NANOBIOTIX SA - ADR (NBTX) Top Institutional Shareholders

NANOBIOTIX SA - ADR (NBTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $175.93M in NBTX holdings during the latest filing period.

Johnson & Johnson is currently the largest disclosed institutional shareholder of NBTX tracked by InsiderSet, reporting ownership valued at approximately $173.61M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $202.85M, representing an estimated gain of +16.84% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed NBTX value among the investors covered in this analysis. Major shareholders include Johnson & Johnson, Morgan Stanley, Optiver Holding B.V., and several other long-term asset managers with concentrated positions in NANOBIOTIX SA - ADR (NBTX).

This page ranks the largest institutional NBTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

15

Total Reported Value

$175.93M

Largest Holder

Johnson & Johnson

Largest Position

$173.61M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

16

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Johnson & Johnson26.61%5,623,816$173,607,200$202,851,043+$29,243,843+16.84%
Morgan Stanley0.00%36,274$1,119,778$1,308,403+$188,625+16.84%
Optiver Holding B.V.0.02%13,501$416,776$486,981+$70,205+16.84%
Marshall Wace, Llp0.00%9,239$285,207$333,251+$48,044+16.85%
Ubs Group Ag0.00%5,557$171,545$200,441+$28,896+16.84%
Bnp Paribas Financial Markets0.00%3,559$109,866$128,373+$18,507+16.85%
Rhumbline Advisers0.00%2,281$70,409$82,276+$11,867+16.85%
Royal Bank Of Canada0.00%1,825$56,000$65,828+$9,828+17.55%
Eversource Wealth Advisors, Llc0.00%882$46,499$31,814-$14,685-31.58%
Gamma Investing Llc0.00%828$25,560$29,866+$4,306+16.85%
Osaic Holdings, Inc.0.00%500$15,435$18,035+$2,600+16.84%
Wells Fargo & Company/Mn0.00%200$6,174$7,214+$1,040+16.84%
National Bank Of Canada0.00%13$394$469+$75+19.01%
Citigroup Inc0.00%1$31$36+$5+16.35%
Tower Research Capital Llc (Trc)0.00%1$31$36+$5+16.35%

Frequently asked questions about NBTX

  • Who owns the most NBTX stock?

    The largest holders of NBTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NANOBIOTIX SA - ADR (NBTX).

  • Is NBTX widely held by superinvestors?

    Many widely followed stocks like NBTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NBTX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.